Geode Capital Management’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.5M | Buy |
|
|||||
|
2025
Q1 | $20.5M | Buy |
|
|||||
|
2024
Q4 | $44.5M | Buy |
|
|||||
|
2024
Q3 | $66.8M | Buy |
|
|||||
|
2024
Q2 | $62.6M | Buy |
|
|||||
|
2024
Q1 | $37.1M | Buy |
|
|||||
|
2023
Q4 | $12.4M | Buy |
|
|||||
|
2023
Q3 | $7.69M | Buy |
|
|||||
|
2023
Q2 | $8.32M | Buy |
|
|||||
|
2023
Q1 | $6.55M | Buy |
|
|||||
|
2022
Q4 | $6.33M | Buy |
|
|||||
|
2022
Q3 | $6.78M | Buy |
|
|||||
|
2022
Q2 | $3.43M | Buy |
|
|||||
|
2022
Q1 | $4.71M | Buy |
|
|||||
|
2021
Q4 | $5.74M | Buy |
|
|||||
|
2021
Q3 | $6.75M | Buy |
|
|||||
|
2021
Q2 | $8.72M | Buy |
|
|||||
|
2021
Q1 | $4.52M | Buy |
|
|||||
|
2020
Q4 | $4.96M | Buy |
|